4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.46
+0.01 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
9.42
-0.04 (-0.42%)
After-hours: Apr 28, 2026, 4:10 PM EDT

4D Molecular Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
-140.11-160.87-100.84-107.49-71.32
Upgrade
Depreciation & Amortization
7.636.715.753.883.02
Upgrade
Loss (Gain) From Sale of Investments
-4.73-7.18-1.241.060.72
Upgrade
Stock-Based Compensation
22.0226.1819.7517.2113.89
Upgrade
Other Operating Activities
-0.050.040.16-00.09
Upgrade
Change in Accounts Receivable
---0.051.44
Upgrade
Change in Accounts Payable
6.770.870.9-1.642.29
Upgrade
Change in Unearned Revenue
-0.210.07-0.72-3.13-14.72
Upgrade
Change in Other Net Operating Assets
-0.39-0.40.453.39-4.54
Upgrade
Operating Cash Flow
-109.08-134.59-75.79-86.69-69.13
Upgrade
Capital Expenditures
-0.54-3.79-2.77-11.54-9.11
Upgrade
Investment in Securities
-92.44-298.65118.49-5.51-163.57
Upgrade
Investing Cash Flow
-92.97-302.44115.72-17.05-172.68
Upgrade
Issuance of Common Stock
112.96337.25156.833.55118.09
Upgrade
Other Financing Activities
----0.47-
Upgrade
Financing Cash Flow
112.96337.25156.833.09118.09
Upgrade
Net Cash Flow
-89.1-99.77196.76-100.65-123.73
Upgrade
Free Cash Flow
-109.62-138.37-78.56-98.22-78.24
Upgrade
Free Cash Flow Margin
-128.65%-373975.68%-379.11%-3139.05%-433.77%
Upgrade
Free Cash Flow Per Share
-1.89-2.56-2.01-3.04-2.82
Upgrade
Levered Free Cash Flow
-54.15-82.29-46.48-59.7-41
Upgrade
Unlevered Free Cash Flow
-54.15-82.29-46.48-59.7-41
Upgrade
Change in Working Capital
6.170.540.63-1.34-15.53
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.